ARSB: Defects in ARSB are the cause of mucopolysaccharidosis type 6 (MPS6); also known as Maroteaux-Lamy syndrome. MPS6 is an autosomal recessive lysosomal storage disease characterized by intracellular accumulation of dermatan sulfate. Clinical features can include abnormal growth, short stature, stiff joints, skeletal malformations, corneal clouding, hepatosplenomegaly, and cardiac abnormalities. A wide variation in clinical severity is observed. Arylsulfatase B activity is defective in multiple sulfatase deficiency (MSD). A clinically and biochemically heterogeneous disorder caused by the simultaneous impairment of all sulfatases, due to defective post-translational modification and activation. It combines features of individual sulfatase deficiencies such as metachromatic leukodystrophy, mucopolysaccharidosis, chondrodysplasia punctata, hydrocephalus, ichthyosis, neurologic deterioration and developmental delay. Arylsulfatase B activity is impaired in multiple sulfatase deficiency due to mutations in SUMF1. SUMF1 mutations result in defective post-translational modification of ARSB at residue Cys- 91 that is not converted to 3-oxoalanine. Belongs to the sulfatase family. 2 isoforms of the human protein are produced by alternative splicing.
Protein type: Glycan Metabolism - glycosaminoglycan degradation; Hydrolase; EC 3.1.6.12
Chromosomal Location of Human Ortholog: 5q14.1
Cellular Component: Golgi apparatus; lysosomal lumen; cell surface; mitochondrion; rough endoplasmic reticulum; lysosome; endoplasmic reticulum lumen
Molecular Function: N-acetylgalactosamine-4-sulfatase activity; arylsulfatase activity; metal ion binding
Biological Process: lysosomal transport; central nervous system development; sphingolipid metabolic process; glycosaminoglycan metabolic process; pathogenesis; post-translational protein modification; chondroitin sulfate metabolic process; cellular protein metabolic process; response to estrogen stimulus; lysosome organization and biogenesis; carbohydrate metabolic process; response to methylmercury; chondroitin sulfate catabolic process; autophagy; glycosphingolipid metabolic process; response to nutrient; response to pH
Disease: Mucopolysaccharidosis Type Vi
Show more